Ressourcen

Dieser Abschnitt enthält internationale Forschungsergebnisse und kann auf Indikationen verweisen, die nicht in allen Regionen zugelassen sind. Bitte konsultieren Sie vor der Anwendung die lokal zugelassenen Indikationen.

Filtern nach:

Suche
RAMAT GAN, Israel, July 13, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in connected home ultrasound technology, today announced that it has been selected to participate
RAMAT GAN, Israel, June 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health, a leading
Ramat Gan, Israel, Jan. 21, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at
This quarter: 2 new peer-reviewed publications | Expansion in Europe | Growth of Hospital-at-Home initiatives | 3 new U.S. commercial hires | Presence at 5 international conferences
First commercial adoptions in the U.S., marking a major step forward in expanding access to home ultrasound New clinical evidence - Using visual biofeedback for pre-labor training! How Sheba Medical

OMER, Israel, Feb. 9, 2026 /PRNewswire/ – Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a maternal-fetal

Am Puls der Zeit bleiben

Wir laden Sie ein, sich für unseren vierteljährlich erscheinenden Newsletter zu registrieren, um auf dem Laufenden zu bleiben

Häufig gestellte Fragen

Häufig gestellte Fragen